Erasca, Inc. (ERAS)
17.88
-0.15
(-0.83%)
USD |
NASDAQ |
Aug 31, 16:00
17.81
-0.07
(-0.39%)
After-Hours: 05:39
Erasca Cash from Operations (TTM) : -98.02M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -98.02M |
| March 31, 2026 | -91.28M |
| December 31, 2025 | -95.46M |
| September 30, 2025 | -98.31M |
| June 30, 2025 | -99.07M |
| March 31, 2025 | -107.72M |
| December 31, 2024 | -109.42M |
| September 30, 2024 | -109.64M |
| June 30, 2024 | -111.34M |
| March 31, 2024 | -108.11M |
| December 31, 2023 | -101.22M |
| September 30, 2023 | -102.80M |
| Date | Value |
|---|---|
| June 30, 2023 | -102.63M |
| March 31, 2023 | -103.82M |
| December 31, 2022 | -103.26M |
| September 30, 2022 | -99.37M |
| June 30, 2022 | -98.65M |
| March 31, 2022 | -89.74M |
| December 31, 2021 | -79.60M |
| September 30, 2021 | -70.21M |
| June 30, 2021 | -54.47M |
| March 31, 2021 | -42.74M |
| December 31, 2020 | -32.69M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Revolution Medicines, Inc. | -1.223B |
| Tango Therapeutics, Inc. | -143.90M |
| Cogent Biosciences, Inc. | -307.54M |
| Apogee Therapeutics, Inc. | -243.89M |
| Arrowhead Pharmaceuticals, Inc. | -59.06M |